JENNETTE BERRY: Open Payments
NPI 1942311972 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$872 in 42 payments from 13 companies in 2025. Trend: 2023 $730 · 2024 $822 · 2025 $872
Food & beverage: $827Education: $45
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $231 |
| SANOFI-AVENTIS U.S. LLC | 1 | $146 |
| Lilly USA, LLC | 9 | $113 |
| ABBVIE INC. | 5 | $83 |
| ViiV Healthcare Company | 2 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| PFIZER INC. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Ardelyx, Inc. | 1 | $27 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
Products named: TZIELD, Rybelsus, VRAYLAR, Wegovy, MOUNJARO, APRETUDE, Kerendia, PREVNAR 20.
Industry payments across IL — which companies pay providers there.
